Compare WPRT & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WPRT | MDCX |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.7M | 31.1M |
| IPO Year | 1995 | N/A |
| Metric | WPRT | MDCX |
|---|---|---|
| Price | $2.13 | $1.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.50 | ★ $23.50 |
| AVG Volume (30 Days) | 112.3K | ★ 295.8K |
| Earning Date | 11-10-2025 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $290,323,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 140.81 | N/A |
| 52 Week Low | $1.54 | $1.14 |
| 52 Week High | $4.77 | $8.94 |
| Indicator | WPRT | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 59.12 | 25.48 |
| Support Level | $2.05 | $1.14 |
| Resistance Level | $2.31 | $1.48 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 48.00 | 11.76 |
Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.